YAP1 and colorectal carcinoma: A study based on a collection of liver metastases resected from CRC patients having received or not having received neo-adjuvant chemotherapy further established that YAP1 mRNA levels were increased in treated vs. untreated patients and that YAP1 expression correlated with poor OS and disease-free survival [19].